Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJourney Medical Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.26 | -$0.21 | -$0.24 |
| Q2 2024 | 1 | -$0.16 | -$0.13 | -$0.14 |
| Q3 2024 | 1 | -$0.19 | -$0.15 | -$0.17 |
| Q4 2024 | 3 | -$0.19 | -$0.18 | -$0.18 |
| Q1 2025 | 1 | -$0.11 | -$0.09 | -$0.10 |
| Q2 2025 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q3 2025 | 1 | $0.06 | $0.08 | $0.07 |
| Q4 2025 | 1 | $0.09 | $0.11 | $0.11 |
Journey Medical Corporation Earnings Date And Information
Journey Medical Corporation last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.12 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.05. The company had revenue of 14.63 M for the quarter and had revenue of 79.18 M for the year. Journey Medical Corporation has generated $0 earnings per share over the last year ($-0.21 diluted earnings per share) and currently has a price-to-earnings ratio of -5.03. Journey Medical Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Journey Medical Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.17 | -$0.12 | 0.05 | $14.39 M | $14.63 M |
| 08/12/2024 | Q2 2024 | -$0.17 | $13.89 M | $14.86 M | ||
| 05/14/2024 | Q1 2024 | -$0.53 | $13.03 M | |||
| 03/28/2024 | Q4 2023 | -$0.11 | $15.26 M | |||
| 11/09/2023 | Q3 2023 | $0.91 | $16.90 M | $34.54 M | ||
| 08/10/2023 | Q2 2023 | -$0.46 | $14.80 M | $17.17 M | ||
| 05/22/2023 | Q1 2023 | -$0.44 | -$0.56 | -0.12 | $12.21 M | |
| 03/30/2023 | Q4 2022 | -$0.60 | $15.97 M | |||
| 11/10/2022 | Q3 2022 | -$0.34 | -$0.57 | -0.23 | $17.65 M | $16.12 M |
| 08/09/2022 | Q2 2022 | -$0.25 | -$0.43 | -0.18 | $21.30 M | $18.29 M |
| 05/10/2022 | Q1 2022 | -$0.18 | -$0.08 | 0.1 | $23.30 M | |
| 03/28/2022 | Q4 2021 | -$1.64 | $17.52 M | |||
| 12/15/2021 | Q3 2021 | -$1.16 | $19.46 M | $19.61 M | ||
| 06/29/2021 | Q2 2021 | -$1.30 | $15.29 M | |||
| 03/30/2021 | Q1 2021 | $0.03 | $10.72 M | |||
| 12/30/2020 | Q4 2020 | $0.15 | $13.72 M | |||
| 09/29/2020 | Q3 2020 | $0.00 | $9.45 M | |||
| 06/29/2020 | Q2 2020 | $0.03 | $9.42 M | |||
| 03/30/2020 | Q1 2020 | $0.13 | $10.68 M | |||
| 11/05/2019 | Q3 2019 | -$1.30 | -$1.06 | 0.24 | $11.53 M |
Journey Medical Corporation Earnings: FAQ's
When is Journey Medical Corporation's earnings date?
Journey Medical Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
Did Journey Medical Corporation beat their earnings estimates last
quarter?
In the previous quarter, Journey Medical Corporation (:DERM) reported $-0.12 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.05.
How can I listen to Journey Medical Corporation's earnings conference
call?
The conference call for Journey Medical Corporation's latest earnings report can be listened to online.
How can I read Journey Medical Corporation's conference call transcript?
The conference call transcript for Journey Medical Corporation's latest earnings report can be read online.
How much revenue does Journey Medical Corporation generate each year?
Journey Medical Corporation (:DERM) has a recorded annual revenue of $79.18 M.
How much profit does Journey Medical Corporation generate each year?
Journey Medical Corporation (:DERM) has a recorded net income of $79.18 M. Journey Medical Corporation has generated $-0.21 earnings per share over the last four quarters.
What is Journey Medical Corporation's price-to-earnings ratio?
Journey Medical Corporation (:DERM) has a price-to-earnings ratio of -5.03 and price/earnings-to-growth ratio is 0.